- Home
- BIDU vs KTTA Comparison
BIDU vs KTTA Comparison
Compare BIDU & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIDU
- KTTA
- Stock Information
- Founded
- BIDU 2000
- KTTA 2020
- Country
- BIDU China
- KTTA United States
- Employees
- BIDU N/A
- KTTA N/A
- Industry
- BIDU Computer Software: Programming Data Processing
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- BIDU Technology
- KTTA Health Care
- Exchange
- BIDU Nasdaq
- KTTA Nasdaq
- Market Cap
- BIDU 28.5B
- KTTA 5.5M
- IPO Year
- BIDU 2005
- KTTA 2021
- Fundamental
- Price
- BIDU $87.00
- KTTA $0.68
- Analyst Decision
- BIDU Strong Buy
- KTTA
- Analyst Count
- BIDU 10
- KTTA 0
- Target Price
- BIDU $111.60
- KTTA N/A
- AVG Volume (30 Days)
- BIDU 2.2M
- KTTA 142.8K
- Earning Date
- BIDU 08-21-2025
- KTTA 08-12-2025
- Dividend Yield
- BIDU N/A
- KTTA N/A
- EPS Growth
- BIDU 34.31
- KTTA N/A
- EPS
- BIDU 10.01
- KTTA N/A
- Revenue
- BIDU $18,475,022,401.00
- KTTA N/A
- Revenue This Year
- BIDU $3.12
- KTTA N/A
- Revenue Next Year
- BIDU $5.62
- KTTA N/A
- P/E Ratio
- BIDU $8.68
- KTTA N/A
- Revenue Growth
- BIDU N/A
- KTTA N/A
- 52 Week Low
- BIDU $74.71
- KTTA $0.67
- 52 Week High
- BIDU $116.25
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- BIDU 50.28
- KTTA 32.67
- Support Level
- BIDU $84.82
- KTTA $0.67
- Resistance Level
- BIDU $91.25
- KTTA $0.77
- Average True Range (ATR)
- BIDU 1.40
- KTTA 0.04
- MACD
- BIDU 0.24
- KTTA 0.01
- Stochastic Oscillator
- BIDU 47.04
- KTTA 14.02
About BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).